EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A monomeric envelope glycoprotein cytoplasmic tail is sufficient for HIV-1 Gag lattice trapping and incorporation

Nicholas S Groves, Austin R Clark, Rebekah S Aguilar, Yuta Hikichi, Anastasiia Kostenko, Merissa M Bruns, Alegra T Aron, Eric O Freed iD, Schuyler B van Engelenburg iD

Journal of Virology · 2025

DOI: 10.1128/jvi.02105-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Nicholas S Groves und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Cellular Biophysics Program, Department of Biological Sciences, University of Denver, Denver, Colorado, USA. Hauptthemen laut MEDLINE: HIV-1, env Gene Products, Human Immunodeficiency Virus, Virus Assembly, gag Gene Products, Human Immunodeficiency Virus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To become infectious, assembling enveloped viruses must acquire viral glycoproteins to mediate downstream infection events. Human immunodeficiency virus-1 (HIV-1) envelope glycoproteins (Env) are well characterized to function as trimers for membrane fusion and entry; however, we sought to understand whether the trimeric structure of Env is required for incorporation into virus particles. Using superresolution live-cell imaging and biochemical assays, we demonstrate that a monomeric receptor chimera containing the Env cytoplasmic tail (Env-CT), known to regulate Env incorporation, is sufficient for lattice trapping and incorporation into virus assembly sites. We also demonstrate that these Env-CT monomers can restrict the incorporation of native Env trimers, competing for an apparently limited number of interaction sites in each assembling particle. Furthermore, this monomeric construct can restrict the incorporation of Env glycoproteins from an evolutionarily distant HIV-1 primary isolate. Our findings support a model where a monomeric Env-CT mediates Env incorporation, with this mechanism of Env incorporation being conserved between distant clades of HIV-1. IMPORTANCE To combat the prevalence of HIV-1 and antiviral resistance, new classes of antivirals are needed. An attractive target for new classes includes virus assembly because released virus particles unable to obtain Env glycoproteins are non-infectious and unable to propagate HIV-1 infection. One requisite to the development of an antiviral targeting Gag-Env coalescence is the need to define the functional units constituting this molecular interface. Although Env functions as an obligatory trimer for virus entry, we demonstrate that a monomeric Env-CT is sufficient for Env incorporation into HIV-1 particles. Monomeric Env-CT displayed saturability in viral lattices and the ability to compete with native Env trimers for particle incorporation. These results suggest a less complex Env-CT structure mediates virus incorporation and that Env-CT mimetics could yield broad competitive activity against HIV-1 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1env Gene Products, Human Immunodeficiency VirusVirus Assemblygag Gene Products, Human Immunodeficiency VirusHumansHEK293 CellsProtein MultimerizationHIV InfectionsVirionVirus InternalizationCell Line

Stichwörter der Autor:innen

EnvGagHIV-1biochemistryglycoprotein incorporationsingle-particle trackingvirus assembly

Substanzen

env Gene Products, Human Immunodeficiency Virusgag Gene Products, Human Immunodeficiency Virus

Autor:innen und Institutionen

  • Molecular and Cellular Biophysics Program, Department of Biological Sciences, University of Denver, Denver, Colorado, USA.
  • Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
  • Department of Chemistry and Biochemistry, University of Denver, Denver, Colorado, USA.

ORCID-Profile: Eric O Freed, Schuyler B van Engelenburg

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Groves, N. S., Clark, A. R., Aguilar, R. S., Hikichi, Y., Kostenko, A., Bruns, M. M., Aron, A. T., Freed, E. O., & van Engelenburg, S. B. (2025). A monomeric envelope glycoprotein cytoplasmic tail is sufficient for HIV-1 Gag lattice trapping and incorporation. Journal of Virology. https://doi.org/10.1128/jvi.02105-24

Vancouver

Groves NS, Clark AR, Aguilar RS, Hikichi Y, Kostenko A, Bruns MM, et al. A monomeric envelope glycoprotein cytoplasmic tail is sufficient for HIV-1 Gag lattice trapping and incorporation. Journal of Virology. 2025. doi:10.1128/jvi.02105-24

BibTeX
@article{Groves2025,
  author = {Groves, Nicholas S and Clark, Austin R and Aguilar, Rebekah S and Hikichi, Yuta and Kostenko, Anastasiia and Bruns, Merissa M and Aron, Alegra T and Freed, Eric O and van Engelenburg, Schuyler B},
  title = {A monomeric envelope glycoprotein cytoplasmic tail is sufficient for HIV-1 Gag lattice trapping and incorporation},
  journal = {Journal of Virology},
  year = {2025},
  doi = {10.1128/jvi.02105-24}
}
Kostenlos starten →